Studies have shown that down-regulating IL-6, IL-17RA and tumor necrosis factor-alpha (TNF-α) levels can effectively improve the pathological changes of gastric mucosa tissue and hinder the development of PLGC into gastric cancer [11]. The gene discussed is IL6; the disease is gastric cancer.